跳至主要内容
临床试验/NCT02280759
NCT02280759已完成1 期

Efficacy of Gelatin Tannate in Treatment Acute Gastroenteritis in Children: A Double Blind Randomized, Placebo- Controlled Trial .

Medical University of Warsaw1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2014年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
72
试验地点
1
主要终点
Duration of diarrhea

研究概览

简要总结

Gelatin tannate possesses astringent, antibacterial, and anti-inflammatory properties. It is increasingly being marketed as an antidiarrheal drug. A randomized, double blind, placebo-control trial was performed to assess the effectiveness of GT in management of children with acute gastroenteritis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
— 至 5 Years(Child)
性别
All
接受健康志愿者

入选标准

  • children < 5 years old
  • diarrhea (defined as the passage of 3 or more loose or watery stools per day) for > 1 day but < 5 days
  • inform consent sign

排除标准

  • regularly used antibiotics, probiotics, gelatin tannate, diosmectite, racecadotril within 7 days before admission
  • underlying gastrointestinal tract disorder presenting with diarrhea
  • breastfeeding >50%
  • malnutrition (weight/high <3pc)

研究组 & 干预措施

Gelatin Tannate

Active Comparator

Gelatin Tannate:

4 times 250 mg/daily for 5 days for children under 3. years old or 4 times 500mg/daily for 5 days for children older then 3. years and under 5 years.

干预措施: Gelatin Tannate (Drug)

Placebo

Placebo Comparator

Placebo consists of an identical formulation, except active substance.

干预措施: Placebo (Drug)

结局指标

主要结局

Duration of diarrhea

时间窗: 7 days

time till the first normal stool from the onset of diarrhea or normalization number of stools and last those for 48hours

次要结局

  • Need of intravenous rehydration due to diarrhea(7 days)
  • Need of hospitalization in outpatients(7 days)
  • Vomiting(How many times for 7days)
  • Weight gain(7 days)
  • Diarrhea recurrence(7 days)
  • Frequency of watery stools(7 days)
  • Adverse effects(7 days)
  • Severity of diarrhea due to modified Vesikari score(7 days)

研究者

发起方
Medical University of Warsaw
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验